Efficacy of High and Low Intensity Percutaneous Electrolysis for the Treatment of Myofascial Pain Syndrome

Sponsor
Universidad Francisco de Vitoria (Other)
Overall Status
Completed
CT.gov ID
NCT04390438
Collaborator
(none)
15
1
3
2.3
6.5

Study Details

Study Description

Brief Summary

Muscle pain is frequently attributed to myofascial pain syndrome (MPS) in which myofascial trigger points (MTrP) are a characteristic feature. Dry needling is a frequent clinical practice to manage MPS but few evidence is published about percutaneous electrolysis effects for the treatment of MPS.

This is a randomized clinical trial with 3 parallel groups: 1) High intensity-short time percutaneous electrolysis; 2) Low intensity-long time percutaneous electrolysis; 3) dry needling control group.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Percutaneous Electrolysis
  • Procedure: Dry needling
N/A

Detailed Description

The current study aimed to evaluate changes in rectus femurs active trigger points and patellar tendon pain pressure thresholds and subjective anterior knee pain perception after application of two percutaneous electrolysis methods using a same charge (high intensity and low intensity) compared to a dry needling group in patients with patellofemoral pain syndrome (PFPS)

Fifteen patients diagnosed with unilateral PFPS were divided in two experimental groups (high intensity percutaneous electrolysis and low intensity percutaneous electrolysis) and one active control group (dry needling. The duration of the study was 7 days with only one intervention. Pain pressure thresholds were assessed using an algometer before the intervention, immediately after the intervention and after 7 days and a Visual Analogue Scale was used before the treatment and after 7 days to rate the subjective anterior knee pain perception. Also a VAS was used to rate the pain perception during the intervention

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized Clinical trial with 3 parallel groups; 2 experimental groups and 1 control groupRandomized Clinical trial with 3 parallel groups; 2 experimental groups and 1 control group
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Efficacy of High and Low Intensity Percutaneous Electrolysis for the Treatment of Myofascial Pain Syndrome: A Pilot Study
Actual Study Start Date :
Feb 17, 2020
Actual Primary Completion Date :
Mar 30, 2020
Actual Study Completion Date :
Apr 27, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: High-Intensity short time percutaneous electrolysis

Application of a 0,66uA galvanic current in the active TrP through a needle during 10 seconds. During the 20 seconds left necessary to blind the patient and the examiner, the needle was inside but with no electrical current

Procedure: Percutaneous Electrolysis
Needle emplacement with a galvanic electrical current

Experimental: Low-Intensity long time percutaneous electrolysis

Application of a 0,22uA galvanic current in the active TrP through a needle during 30 seconds

Procedure: Percutaneous Electrolysis
Needle emplacement with a galvanic electrical current

Active Comparator: Dry needling

One acupuncture needle was placed in the active TrP to produce a local twitch response during 30 seconds

Procedure: Dry needling
Needle emplacement without electrical current nor substance

Outcome Measures

Primary Outcome Measures

  1. Pressure Pain Threshold (Trigger Point) [7 days]

    Algometry (Wagner analogical algometer)

  2. Pressure Pain Threshold (Patellar Tendon) [7 days]

    Algometry (Wagner analogical algometer)

Secondary Outcome Measures

  1. Subjective pain perception [7 days]

    Visual Analogue Scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Athletes with knee pain

  • Presence of at least one active Trigger point

Exclusion Criteria:
  • Farmacologic treatment

  • Surgery or traumas

  • Skin alterations or infections

  • Prior 6 weeks DN nor PT treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Camilo Jose Cela University Villanueva de la Cañada Madrid Spain 28692

Sponsors and Collaborators

  • Universidad Francisco de Vitoria

Investigators

  • Principal Investigator: Juan Antonio Valera-Calero, PT, Msc, Camilo Jose Cela University
  • Study Director: Alberto Sanchez-Mayoral-Martín, PT, Free professional practice

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Universidad Francisco de Vitoria
ClinicalTrials.gov Identifier:
NCT04390438
Other Study ID Numbers:
  • 50997093
First Posted:
May 15, 2020
Last Update Posted:
May 15, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Universidad Francisco de Vitoria
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 15, 2020